当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Manu Arnold
Integration of Ayurveda into our current health care investigate programs is basic to making progress in global wellness and in infection prevention and control, particularly for cancer. Ayurveda advances rebuilding of the natural healing instruments existing within the body for ideal resistance, resilience, and wellbeing. Ayurveda also has an inexhaustible resource of botanical items containing assorted Pharmaco-active fixings and centuries of experience of clinical applications for health benefits. But there's a lack of evidence–based research to illustrate its viability and potential. This 2-part review is written from the perspective of a western-trained biomedical scientist and student of Ayurveda. Ayurvedic botanical resources utilized for cancer and inquire about studies will be talked about on chosen herbal compounds. Inquire about gaps and opportunities will be identified to direct development of research programs to approve security and viability of these treatments. Imperatively, the use of Ayurvedic modalities isn't planning to substitute for allopathic medications for cancer but as an integrative component for prevention and rebuilding of quality and immunity post treatment.